AstraZeneca shared the topline result from the placebo-controlled ... before AZ and its partner Merck were able to cross the ...

The two parties, together with AstraZeneca, will cooperate on scientific research ... Health Engineering was established ...

As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.

Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...

AstraZeneca has exceeded market expectations with its third-quarter earnings and raised its outlook for the 2024 fiscal year, ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The Philadelphia Phillies recently raised close to $500 million in capital from three new investors, according to two people ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Europe's STOXX 600 inched up 0.1% on Tuesday, driven by industrials while investors monitored U.S. election outcomes. Italian ...

Britain's benchmark FTSE 100 edged lower on Tuesday, hurt by AstraZeneca's fall on a potential China probe, while investors ...

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be implicated in the largest insurance fraud case ...